N-Fmoc-N'-trityl-D-histidine is a protected derivative of the amino acid D-histidine. It features two orthogonal protecting groups: the base-labile 9-fluorenylmethoxycarbonyl (Fmoc) group on the α-amino function and the acid-labile trityl (Trt) group on the imidazole side chain of histidine. This specific protection scheme is crucial for its primary application. This compound is a key building block in solid-phase peptide synthesis (SPPS) employing the Fmoc strategy. The D-configuration of the histidine residue is essential for synthesizing peptides containing non-natural or modified sequences, which are often required in pharmaceutical research. The Trt group effectively protects the imidazole nitrogen during synthesis, preventing side reactions and ensuring high-purity peptide products. It is therefore a fundamental reagent for producing peptide-based drug candidates, bioactive probes, and research peptides. Its use is almost exclusively dedicated to peptide chemistry within life sciences and medicinal chemistry. While structurally an amine and a heterocycle, its highly specialized role as a protected, non-natural amino acid precursor places it firmly in the domain of bioconjugate and peptide synthesis reagents rather than as a general-purpose organic synthesis building block.